WallStreetZenWallStreetZen

NASDAQ: IMCC
IM Cannabis Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$1.48-0.06 (-3.9%)
Updated Apr 21, 2025
IMCC Price
$1.48
Fair Value Price
N/A
Market Cap
$4.55M
52 Week Low
$1.30
52 Week High
$7.86
P/E
-0.47x
P/B
1.25x
P/S
0.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$37.52M
Earnings
-$7.35M
Gross Margin
15.6%
Operating Margin
-13.22%
Profit Margin
-19.6%
Debt to Equity
6.87
Operating Cash Flow
-$748k
Beta
0.61
Next Earnings
May 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A

IMCC Overview

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine IMCC's potential to beat the market

View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical

Industry Rating
B
IMCC
RankedUnranked of 54

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Amneal Pharmaceuticals (AMRX)
$7.13A
Hutchmed (HCM)
$13.89A
Supernus Pharmaceuticals (SUPN)
$30.29A
View Top Pharmaceutical Stocks

Be the first to know about important IMCC news, forecast changes, insider trades & much more!

IMCC News

Overview

Due Diligence Score

–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how IMCC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IMCC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IMCC is good value based on its book value relative to its share price (1.25x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.98x)
P/B vs Industry Valuation
IMCC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IMCC due diligence checks available for Premium users.

Valuation

IMCC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.47x
Industry
20.59x
Market
27.14x

IMCC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.25x
Industry
1.98x
IMCC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IMCC's financial health

Profit margin

Revenue
$9.3M
Net Income
-$18.8k
Profit Margin
-0.2%
IMCC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
IMCC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$27.2M
Liabilities
$25.0M
Debt to equity
6.87
IMCC's short-term liabilities ($24.25M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMCC's short-term assets ($16.23M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMCC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IMCC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
$1.4k
Financing
$2.7M
IMCC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IMCC vs Pharmaceutical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
IMCC–$4.55M-4.22%-0.47x1.25x
CPHI–$4.91M+0.47%-0.56x0.63x
SXTC–$3.98M-52.78%0.01x0.27x
SNOAC$3.59M-3.48%-0.92x0.74x
SBFM–$3.49M+3.20%-0.18x0.15x
View Top Pharmaceutical Stocks

IM Cannabis Stock FAQ

What is IM Cannabis's quote symbol?

(NASDAQ: IMCC) IM Cannabis trades on the NASDAQ under the ticker symbol IMCC. IM Cannabis stock quotes can also be displayed as NASDAQ: IMCC.

If you're new to stock investing, here's how to buy IM Cannabis stock.

What is the 52 week high and low for IM Cannabis (NASDAQ: IMCC)?

(NASDAQ: IMCC) IM Cannabis's 52-week high was $7.86, and its 52-week low was $1.30. It is currently -81.23% from its 52-week high and 13.46% from its 52-week low.

How much is IM Cannabis stock worth today?

(NASDAQ: IMCC) IM Cannabis currently has 3,085,452 outstanding shares. With IM Cannabis stock trading at $1.48 per share, the total value of IM Cannabis stock (market capitalization) is $4.55M.

IM Cannabis stock was originally listed at a price of $585.00 in Mar 2, 2021. If you had invested in IM Cannabis stock at $585.00, your return over the last 4 years would have been -99.75%, for an annualized return of -77.59% (not including any dividends or dividend reinvestments).

How much is IM Cannabis's stock price per share?

(NASDAQ: IMCC) IM Cannabis stock price per share is $1.48 today (as of Apr 21, 2025).

What is IM Cannabis's Market Cap?

(NASDAQ: IMCC) IM Cannabis's market cap is $4.55M, as of Apr 23, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

IM Cannabis's market cap is calculated by multiplying IMCC's current stock price of $1.48 by IMCC's total outstanding shares of 3,085,452.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.